["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice]
- PMID: 19197810
- DOI: 10.1055/s-0028-1123994
["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice]
Abstract
Introduction: The efficacy of a multifactorial intervention with antihypertensive drugs, statins and acetylsalicylic acid was shown in the STENO 2 trial of diabetic patients with microalbuminuria. But how good is clinical practice in Germany? The DIG (Diabetes in Germany) study was an prospective survey, analysing the quality of risk factor control and treatment patterns of type 2 diabetics over 4 years between 2002 and 2007.
Methods: A total of 4020 type 2 diabetics (aged 35 - 80 years) were recruited by 238 physicians across Germany. Their medical history, risk factor profile and clinical data were recorded. The quality of control of diabetes, hypertension or hyperlipidemia and the use of aspirin were assessed in 2914 patients at baseline and after 3,7 years.
Results: The mean HbA (1c) value was 6,98 % at baseline and 7,03 at the study end. 42,9 % at the beginning vs. 36,9 % at follow-up had HbA (1c) values above the target level of 6,5 %. Mean blood pressure was 139,3/80.0 compared with 137,3/79.9 mm Hg (p < 0,01), while 24,1 % and 27,0 %, respectively had values above the target level. Mean LDL-cholesterol levels were 3,23 mmol/l and 2,93 mmol/l, respectively, but only 23,2 % and 30,4 % of patients, respectively, reached target levels. There was a significant increase in the use of antihypertensive drugs, statins and acetylsalicylic acid over the four-year period.
Conclusion: Type 2 diabetics in Germany received an acceptable level of treatment for hyperglycaemia, but still more than 60 % of the patients have HbA (1c) values higher than 6,5 %. There are serious deficits in the management of hypertension, hypercholesterolemia and the use of aspirin. Because intensive, multifactorial care of type 2 diabetics leads to reduced rates of death and cardiovascular disorders, these results indicate that the early and meticulous implementation of current treatment guidelines remains a major challenge.
Similar articles
-
Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.Prim Care Diabetes. 2011 Apr;5(1):19-24. doi: 10.1016/j.pcd.2010.09.006. Epub 2010 Oct 27. Prim Care Diabetes. 2011. PMID: 21030327
-
[Glycemic targets and cardiovascular morbi-mortality].Presse Med. 2013 May;42(5):855-60. doi: 10.1016/j.lpm.2012.02.052. Epub 2012 Dec 31. Presse Med. 2013. PMID: 23286961 Review. French.
-
Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.Cardiol J. 2015;22(2):150-9. doi: 10.5603/CJ.a2014.0067. Epub 2014 Oct 9. Cardiol J. 2015. PMID: 25299503
-
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.Vasc Health Risk Manag. 2006;2(4):507-14. doi: 10.2147/vhrm.2006.2.4.507. Vasc Health Risk Manag. 2006. PMID: 17323606 Free PMC article.
-
Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.Cardiovasc J Afr. 2015 Jul-Aug;26(4):188-92. doi: 10.5830/CVJA-2015-050. Cardiovasc J Afr. 2015. PMID: 26407221 Free PMC article. Review.
Cited by
-
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.BMC Nephrol. 2016 Jun 11;17(1):59. doi: 10.1186/s12882-016-0273-z. BMC Nephrol. 2016. PMID: 27286816 Free PMC article.
-
The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial.Cardiovasc Diabetol. 2010 Jun 15;9:23. doi: 10.1186/1475-2840-9-23. Cardiovasc Diabetol. 2010. PMID: 20550650 Free PMC article. Clinical Trial.
-
Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences.Eur J Health Econ. 2015 Apr;16(3):305-11. doi: 10.1007/s10198-014-0575-7. Epub 2014 Mar 12. Eur J Health Econ. 2015. PMID: 24619251
-
Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary.Wien Klin Wochenschr. 2013 Jul;125(13-14):371-80. doi: 10.1007/s00508-013-0379-2. Epub 2013 Jul 4. Wien Klin Wochenschr. 2013. PMID: 23824265
-
Blood Pressure Control Has Improved in People with and without Type 2 Diabetes but Remains Suboptimal: A Longitudinal Study Based on the German DIAB-CORE Consortium.PLoS One. 2015 Jul 29;10(7):e0133493. doi: 10.1371/journal.pone.0133493. eCollection 2015. PLoS One. 2015. PMID: 26221962 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous